Philips Set to Launch Enhanced Neurovascular Imaging System at ECR

News
Article

Emphasizing upgraded angio suite capabilities as well as improved 2D and 3D imaging, Philips will unveil the Azurion Neuro Biplane System at the European Congress of Radiology.

In order to help enhance interventional workflows for neurovascular procedures, Philips is slated to debut the Azurion Neuro Biplane System at the European Congress of Radiology (ECR).

The Azurion Neuro Biplane System offers an integrated combination of 2D and 3D imaging with low-dose imaging capabilities to enhance stroke assessment and timely precision intervention in neurovascular procedures, according to Philips.

Philips Set to Launch Enhanced Neurovascular Imaging System at ECR

Designed to enhance interventional workflows for stroke assessment and neurovascular procedures, the Azurion Neuro Biplane System is slated to launch at the European Congress of Radiology (ECR). (Image courtesy of Philips.)

“Working closely with leading interventionists, we designed the latest Azurion neuro biplane (system) to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment,” said Mark Stoffels, the business leader of image guided therapy systems at Philips. “Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health.”

The company noted that other key features with the Azurion Neuro Biplane System include automated beam rotation, improved C-arm rotation and X-ray detector positioning flexibility.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.